利用患者来源异种移植模型揭示调控肝细胞癌生长的生物学因素
该研究将93例肝细胞癌和8例胆管癌植入NSG小鼠,系统分析宿主因素并优化PDX平台。部分肝切除的NSG小鼠在植入率、生长和传代方面表现最佳,但总体植入率较低。PDX模型保留亲本肿瘤的组织学和遗传特征,8个模型可用于临床前研究,HCC PDX对瑞戈非尼和索拉非尼敏感性不同,CCA PDX对瑞戈非尼高度敏感。
要点
- 部分肝切除的NSG小鼠是HCC PDX的最佳宿主组合。
- PDX模型保留亲本肿瘤组织学和遗传特征。
- HCC PDX对瑞戈非尼和索拉非尼敏感性存在差异。
核心结论
- PDX模型可实现早期和晚期HCC的功能化,并揭示美国肝细胞癌的独特生物学特征。
研究设计与样本
- 研究植入93例肝细胞癌和8例胆管癌,系统分析宿主因素并优化手术和活检样本的PDX平台。
主要发现
- 部分肝切除的NOD Scid IL-2Rγ-/-小鼠在植入率、生长和传代方面最佳,但总体植入率低。
- PDX模型保留亲本肿瘤的组织学和遗传特征,最终8个模型可用于临床前研究。
- HCC PDX对瑞戈非尼和索拉非尼敏感性不同,CCA PDX对瑞戈非尼高度敏感。
临床怎么用
- PDX模型可用于肝细胞癌的个性化生物学研究和临床前药物敏感性评估。
局限性
- 美国HCC总体植入率低,可能限制PDX模型的广泛应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Several major factors limit our understanding of hepatocellular carcinoma (HCC). First, human HCCs are infrequently biopsied for diagnosis and thus are not often biologically interrogated. Second, HCC initiation and progression are strongly influenced by the cirrhotic microenvironment, and the exact contributions of intrinsic and extrinsic tumor factors are unclear. A powerful approach to examine the personalized biology of liver cancers and the influence of host tissues is with patient-derived xenograft (PDX) models. In Asia, HCCs from patients with hepatitis B virus have been efficiently converted into PDXs, but few parallel efforts from the west have been reported. APPROACH AND RESULTS: In a large-scale analysis, we implanted 93 HCCs and 8 cholangiocarcinomas (CCAs) to systematically analyze host factors and to define an optimized platform for PDX development from both surgical and biopsy samples. NOD Scid IL-2Rγ-/- (NSG) mice that had undergone partial hepatectomy (PHx) represented the best combination of engraftability, growth, and passageability, but overall rates were low and indicative of a unique intrinsic biology for HCCs in the United States. PDX models preserved the histology and genetic features of parental tumors, and ultimately, eight models were usable for preclinical studies. Intriguingly, HCC PDXs were differentially sensitive to regorafenib and sorafenib, and CCA PDXs were also highly sensitive to regorafenib. CONCLUSIONS: PDX models functionalize early and advanced stage HCCs and revealed unique biological features of liver cancers from the United States.
引用
- Zhu M, Li L, Lu T, et al. Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient-Derived Xenograft Assays. Hepatology. 2020. PMID: 31899548. doi:10.1002/hep.31096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。